Results 161 to 170 of about 22,458 (270)

Pharmacological treatment strategies to manage precipitated withdrawal following the administration of buprenorphine in opioid use disorder: A systematic review

Addiction, Volume 121, Issue 5, Page 1083-1099, May 2026.
Abstract Background and aims There has been limited evidence synthesis examining the treatment of buprenorphine precipitated opioid withdrawal (BPOW). We aimed to conduct the first systematic review to assess the clinical utility of any pharmacological intervention in the management of BPOW.
Emmert Roberts, Nicola Kalk, John Strang
wiley   +1 more source

Prehospital Risk Stratification Using Unsupervised Machine Learning in STEMI

European Journal of Clinical Investigation, Volume 56, Issue 5, May 2026.
Machine learning identified three phenotypes with 30‐day mortality of 3.4%, 22.1%, and 75%. Phenotype‐2 reveals an "occult high‐risk" group: hemodynamically stable yet six‐fold higher mortality. ABSTRACT Background ST‐elevation myocardial infarction (STEMI) exhibits substantial clinical heterogeneity complicating prehospital risk stratification ...
Ana Ramos‐Rodríguez, Raúl López‐Izquierdo, Carlos del Pozo Vegas, María Plaza‐Martín, Cristina Tapia‐Ballesteros, Juan F. Delgado Benito, Ancor Sanz‐García, Francisco Martín‐Rodríguez   +7 more
wiley   +1 more source

Racial Disparities in Non-Stigmatized Supportive Care Medication Use in Pancreatic Cancer. [PDF]

J Pain Symptom Manage
Kweyete OMT, Whitner C, Deremer DL, Guo Y, Bian J, Scarton L, Rogers SC, Wilkie DJ, Lou X, Allen JM.   +9 more
europepmc   +1 more source

Perspectives and Requirements of Patients with Prostate Cancer on Mobile Health Interventions During Androgen Deprivation Therapy: A Descriptive Qualitative Study

Journal of Clinical Nursing, Volume 35, Issue 5, Page 2400-2415, May 2026.
ABSTRACT Aim To explore the perceptions of patients with prostate cancer undergoing androgen deprivation therapy towards mobile health interventions. Design The study employed a qualitative descriptive design. Methods Seventeen participants were recruited from tertiary care hospitals from November 2022 to June 2023. The collected data were subsequently
Hongfan Yin, Chen Pan, Jia Gu, Yan Yang
wiley   +1 more source

Impact of antiemetic use on stroke cases from the Japanese Society Aeromedical Service Registration System. [PDF]

J Rural Med
Tanaka N, Nagasawa H, Maekawa C, Ota S, Ohsaka H, Omori K, Yanagawa Y.   +6 more
europepmc   +1 more source

Postoperative Antibiotics Do Not Prevent Surgical Site Infections After Routine Ophthalmic Soft Tissue Surgeries in Dogs—A Retrospective Study

Veterinary Ophthalmology, Volume 29, Issue 3, May 2026.
ABSTRACT Purpose To compare the incidence of surgical site infections (SSI) following routine ophthalmic soft tissue surgeries in dogs receiving (AB) and not receiving (noAB) postoperative antibiotics. Methods Clinical records of dogs that underwent enucleations, wedge resections, medial canthoplasties, and simple and complicated eyelid surgeries with ...
Ana Cristina Piroth, Claudia Busse
wiley   +1 more source

Maropitant Citrate Administration Significantly Decreases the Rate of Peristalsis in the Stomach and Jejunum and Does Not Significantly Alter Intestinal Diameter or Intestinal Wall Thickness in Healthy Adult Dogs

Veterinary Radiology &Ultrasound, Volume 67, Issue 3, May 2026.
ABSTRACT Maropitant citrate (Cerenia) is a neurokinin‐1 (NK‐1) receptor antagonist labeled for the treatment of vomiting in dogs and cats. Anecdotal observation at the authors’ institution suggests that patients receiving maropitant citrate occasionally display sonographic and radiographic signs of diffuse functional ileus.
Jillian Myers, Andra Voges, Robert Werner, Nicola Ritter   +3 more
wiley   +1 more source

Comparison of aprepitant, dexamethasone, and ondansetron with dexamethasone and ondansetron for prevention of postoperative nausea and vomiting in high-risk patients undergoing laparoscopic surgeries: a randomized controlled trial in India. [PDF]

J Minim Invasive Surg
Bala S, Meshram TM, Bhatia P, Rathod D, Kaur M, Kumari K.   +5 more
europepmc   +1 more source

A phase 1 study of ASTX727 plus talazoparib in patients with triple‐negative or hormone resistant/HER2‐negative metastatic breast cancer

Cancer, Volume 132, Issue 8, 15 April 2026.
Abstract Background Poly(adenosine diphosphate ribose) polymerase (PARP) is recruited to DNA damage sites along with epigenetic factors such as DNA methyltransferase 1 (DNMT1). Inhibitors of DNMT modulate reactive oxygen species (ROS)‐cyclic adenosine monophosphate (cAMP)/Protein Kinase A signaling and induce a “BRCAness phenotype” that further ...
Kathy D. Miller, Alexandra Thomas, Sandra Althouse, Yong Zang, Erin Conder, Ryan Burgos, Bryan P. Schneider, Tarah Ballinger, Emily Douglas, Katherine Ansley, H. Josh Jang, Woonbok Chung, Jean‐Pierre Issa, Kenneth P. Nephew, Feyruz V. Rassool   +14 more
wiley   +1 more source

Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies. [PDF]

ESMO Open
Shitara K, Smyth E, Lordick F, Pophale R, Matney C, Matsangou M, Gourgioti G, Oh M, Ranganath R, Klempner SJ.   +9 more
europepmc   +1 more source